康灃生物科技（上海）股份有限公司（股票代码：06922，股票名称：康沣生物-B）于2026年10月2日发布2026年9月股份变动月报，报告期截至2026年9月30日。
截至报告期末，公司注册股本总额为人民币244,705,000元。公司目前拥有H股与非上市股份两类股本，其中H股数量为149,033,579股，相较上月底无新增发行或减持；非上市股份数量为95,671,421股，也未发生增减变动。报告期内，公司未进行库藏股、购回或注销事项，亦无新增股份期权或股权激励计划变动。
报告称，截至本月底，公司股本结构总体稳定，确认符合香港联交所相关的公众持股量要求。公告由董事朱军签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.